Skip to main content

Advertisement

  • Research
  • Open Access

Accuracy of electrocardiographic criteria for atrial enlargement: validation with cardiovascular magnetic resonance

  • 1,
  • 1,
  • 1,
  • 1,
  • 1, 2,
  • 1, 3 and
  • 1Email author
Journal of Cardiovascular Magnetic Resonance200810:7

https://doi.org/10.1186/1532-429X-10-7

©  Tsao et al; licensee BioMed Central Ltd. 2008

  • Received: 18 December 2007
  • Accepted: 25 January 2008
  • Published:

Abstract

Background

Anatomic atrial enlargement is associated with significant morbidity and mortality. However, atrial enlargement may not correlate with clinical measures such as electrocardiographic (ECG) criteria. Past studies correlating ECG criteria with anatomic measures mainly used inferior M-mode or two-dimensional echocardiographic data. We sought to determine the accuracy of the ECG to predict anatomic atrial enlargement as determined by volumetric cardiovascular magnetic resonance (CMR).

Methods

ECG criteria for left (LAE) and right atrial enlargement (RAE) were compared to CMR atrial volume index measurements for 275 consecutive subjects referred for CMR (67% males, 51 ± 14 years). ECG criteria for LAE and RAE were assessed by an expert observer blinded to CMR data. Atrial volume index was computed using the biplane area-length method.

Results

The prevalence of CMR LAE and RAE was 28% and 11%, respectively, and by any ECG criteria was 82% and 5%, respectively. Though nonspecific, the presence of at least one ECG criteria for LAE was 90% sensitive for CMR LAE. The individual criteria P mitrale, P wave axis < 30°, and negative P terminal force in V1 (NPTF-V1) > 0.04s·mm were 88–99% specific although not sensitive for CMR LAE. ECG was insensitive but 96–100% specific for CMR RAE.

Conclusion

The presence of at least one ECG criteria for LAE is sensitive but not specific for anatomic LAE. Individual criteria for LAE, including P mitrale, P wave axis < 30°, or NPTF-V1 > 0.04s·mm are highly specific, though not sensitive. ECG is highly specific but insensitive for RAE. Individual ECG P wave changes do not reliably both detect and predict anatomic atrial enlargement.

Keywords

  • Cardiovascular Magnetic Resonance
  • Negative Predictive Value
  • Left Atrial
  • Primary Pulmonary Hypertension
  • Right Atrial

Introduction

Atrial enlargement is a marker of increased cardiovascular events. Anatomic left atrial (LA) enlargement (LAE) is a marker of left ventricular (LV) diastolic dysfunction [1] and is associated with an abnormal stress test in subjects with known or suspected coronary artery disease [2]. In addition, it is a predictor for the development of atrial fibrillation [3–6], congestive heart failure [6], stroke [7], increased cardiac mortality [7, 8], incidence and survival after myocardial infarction [9–11], and combined cardiovascular events [10, 12]. Right atrial (RA) enlargement (RAE) is associated with increased risk for congestive heart failure [13] and increased mortality in patients with primary pulmonary hypertension [14].

The electrocardiogram (ECG) is used ubiquitously in clinical practice to evaluate patients with cardiac disease. ECG criteria for atrial enlargement have shown poor sensitivity and moderate specificity for detecting enlargement as defined by two-dimensional echocardiography parasternal long axis (PLAX) and four-chamber (4 Ch) measurements [15–23]. However, echocardiographic measures are subject to error due to variability in acquisition of appropriately aligned images, limitations in acoustic windows, and other causes of technical variation. In addition, because the LA is not a sphere with a constant radius [24], uni- or two- dimensional (2-D) echocardiographic measurements may not reflect true chamber size. Cardiovascular magnetic resonance (CMR) imaging can provide images in standardized planes, thereby providing more precise volumetric assessment of cardiac chamber size. We sought to determine the accuracy of the ECG for detection of atrial enlargement (AE) using the gold standard of volumetric CMR.

Methods

Study population

The study population consisted of 275 consecutive subjects referred for CMR either for clinical (n= 255) or research (n = 20) purposes, between February 2001 and July 2004. Clinical CMR indications included evaluation for the following: left ventricular function (n = 111), pulmonary veins (n = 74), coronary arteries (n = 47), perfusion and/or viability (n = 43), cardiomyopathy (n = 38), intracardiac shunt (n = 4), valvular function (n = 3), pericardium (n = 2), myocarditis (n = 1), and cardiac mass (n = 1). Many subjects were referred for more than one indication. Subjects were excluded if no sinus rhythm ECG was available (see below). Age, gender, height, weight, as well as history of atrial fibrillation (AF) and hypertension were recorded. Research subjects gave informed consent according to a protocol approved by the hospital institutional review board.

Electrocardiography

A standard 12-lead ECG was performed on the same day of the CMR in all subjects in sinus rhythm (n = 201). An ECG in sinus rhythm, no more than 35 days from the CMR scan and prior to any pulmonary vein ablation procedures, was obtained for subjects with AF (n = 74). ECG LAE was defined by any one of the following: 1) P wave in any lead > 0.11s, 2) Notched P wave with interpeak duration > 0.04s (P mitrale), 3) P wave axis < 30°, 4) Area of negative P terminal force in lead V1 (NPTF-V1) > 0.04s·mm, or 5) Positive P terminal force in aVL (PPTF-aVL) > 0.5 mm [16, 18, 23, 25]. ECG RAE included 1) P wave in inferior leads II, III, aVF > 2.5 mm or 2) Positive P wave in V1 > 1.5 mm [26, 27]. All ECG determinations were made by one experienced observer (MEJ) blinded to other results.

CMR technique

CMR was performed on a 1.5T whole-body scanner (Gyroscan NT, Philips Medical Systems, NL). Among subjects with AF, the CMR scan was performed prior to any pulmonary vein isolation procedure. Participants were imaged in the supine position with a phased-array five-element cardiac synergy coil for radiofrequency signal reception. Localizing scans were followed by free-breathing axial spin-echo (repetition time 800 ms, echo time 20 ms, field of view 300 mm, matrix size 192 × 512, slice thickness 6 mm, 0.5 mm gap) and end-expiratory, breath-hold, ECG-gated SSFP acquisitions (temporal resolution 33 ms, repetition time 3.1 ms, echo time 1.6 ms, flip angle 60 degrees, field of view 400 mm, matrix size 208 × 256, slice thickness 10 mm, gap = 0).

Image analysis

CMR analyses were performed using dedicated software (EasyVision 5.1, Philips Medical Systems, Best, NL). LA length was measured from the posterior wall to the plane of the mitral annulus, parallel to the long-axis of the heart, in the two-chamber (2 Ch) and four-chamber (4 Ch) orientations on cine SSFP acquisitions at maximum atrial diastole (Figure 1A, B). Maximum atrial diastole was defined as the image immediately preceding the opening of the mitral and tricuspid valves. Similarly, RA length was measured from the posterior wall of the RA to the plane of the tricuspid annulus in the 4 Ch orientation (Figure 1B). LA area in apical 2 Ch and 4 Ch orientation were planimetered by tracing the endocardial border in maximum atrial diastole, excluding the confluence of the pulmonary veins and LA appendage (Figure 1C, D). Similarly, the 4 Ch RA area was planimetered, excluding the confluence of the vena cavae and the atrial appendage (Figure 1D). The borders of the atria were delimited at the planes of the AV annulus and the junctions of venous inflow. Atrial volumes were calculated according to the biplane area-length method, then indexed for body surface area (BSA) [28–30]. Enlarged CMR volume index was defined to be ≥ 55 ml/m2, two standard deviations (SD) above the mean of normal, healthy subjects in published population studies [31–36]. CMR analyses were performed by two experienced observers (CWT, TDO) blinded to other results.
Figure 1
Figure 1

CMR images with representative measurements at atrial end-diastole. (A) Two-chamber (2 Ch) view with left atrial (LA) length measurement. (B) Apical four-chamber (4 Ch) view with LA and right atrial (RA) 4 Ch length measurement. (C) 2 Ch view with LA endocardial border tracings. (D) 4 Ch view with LA and RA endocardial border tracings. P: Posterior. L: Left.

Statistical analysis

Continuous data are presented as mean ± SD. Categorical data are presented as counts and percentages. The difference in continuous measures between subject subgroups was assessed using Student's t test. The difference in categorical measures between subject subgroups and the prevalence of AE among the subject subgroups were assessed using Fisher's exact test. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were used to assess the test performance for ECG LAE and RAE. The accuracy of ECG LAE and RAE were computed individually and in combination. The independent relationships of hypertension and CMR LAE to ECG LAE were further evaluated with logistic regression. A p-value of ≤ 0.05 was considered statistically significant. All statistical analyses were performed using SAS for Windows (v.9.1, SAS Institute, Cary, NC).

Results

Study population

The 275 study subjects consisted of 184 (67%) males, 91 females (age 51 ± 14 years; range 18 to 83 years) who were consecutively referred for clinical or research CMR study, including 27% subjects with a history of AF and 34% with a history of hypertension. For the entire group, CMR LA and RA volumes were 97 ± 38 ml and 79 ± 32 ml, respectively, and LA and RA volume indices were 49 ± 17 ml/m2 and 40 ± 15 ml/m2, respectively. The prevalence of CMR AE and ECG AE is presented in Table 1. Normotensive subjects and those with a history of hypertension had a similar prevalence of CMR LAE (30%, p = 1.0). Compared to subjects in sinus rhythm, subjects with a history of AF had a significantly higher prevalence of CMR LAE and but not CMR RAE (Figure 2).
Figure 2
Figure 2

Prevalence of CMR atrial enlargement (AE) among subjects in sinus rhythm (SR) and with atrial fibrillation (AF). Subjects with AF have a significantly higher prevalence of left (LAE) but not right atrial enlargement (RAE), compared with subjects in SR.

Table 1

Prevalence of Atrial Enlargement by CMR and ECG

LAE

RAE

CMR Criteria

Volume index ≥ 55 ml/m 2

28%

Volume index ≥ 55 ml/m 2

11%

ECG Criteria

Any ECG criteria for LAE

82%

Any ECG criteria for RAE

5%

P > 0.11s

70%

Inferior P waves > 2.5 mm

1%

P mitrale

3%

Positive P wave in V1 > 1.5 mm

4%

P axis < 30°

9%

  

NPTF-V1 > 0.04s·mm

16%

  

PPTF-aVL > 0.5 mm

41%

  

CMR: Cardiovascular magnetic resonance. ECG: Electrocardiography. LAE: Left atrial enlargement. RAE: Right atrial enlargement. P mitrale: Notched P wave with interpeak duration > 0.04s. NPTF-V1 > 0.04s·mm: Area of negative P terminal force in lead V1 > 0.04s·mm. PPTF-aVL: Positive P terminal force in lead aVL. Inferior P waves: P wave in any of the leads II, III, or aVF.

Accuracy of ECG for anatomic atrial enlargement

The accuracy of ECG LAE is presented in Table 2. The presence of at least one ECG LAE criteria had a sensitivity of 90% with a NPV of 84% and specificity of 21% for detection of CMR LAE. When ECG criteria were analyzed independently, P wave > 0.11s offered the highest sensitivity for CMR LAE, with a NPV of 85%. Three individual ECG criteria were very specific for detecting CMR LAE. The presence of P mitrale, P wave axis < 30°, and NPTF-V1 > 0.04s·mm were 99%, 90%, and 88% specific, respectively, for detecting CMR LAE, although these criteria were not sensitive. The presence of P mitrale had a high PPV of 86% for CMR LAE.
Table 2

Accuracy of ECG criteria for Left and Right Atrial Enlargement as Detected by CMR

ECG Criteria

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

LAE

Any ECG Criteria for LAE

90

21

31

84

P > 0.11s

84

35

34

85

P mitrale

8

99

86

74

P axis < 30°

8

90

23

71

NPTF-V1 > 0.04s·mm

37

88

47

76

PPTF-aVL > 0.5 mm

44

60

30

73

RAE

Any ECG Criteria for RAE

17

96

33

91

Inferior P waves > 2.5 mm

7

100

67

90

Positive P wave in V1 > 1.5 mm

10

96

25

90

CMR: Cardiovascular magnetic resonance. ECG: Electrocardiography. PPV: Positive predictive value. NPV: Negative predictive value. LAE: Left atrial enlargement. RAE: Right atrial enlargement. P mitrale: Notched P wave with interpeak duration > 0.04s. NPTF-V1 > 0.04s·mm: Area of negative P terminal force in lead V1 > 0.04s·mm. PPTF-aVL: Positive P terminal force in lead aVL. Inferior P waves: P wave in any of the leads II, III, or aVF.

The ECG was insensitive but highly specific for CMR RAE (Table 2). The presence of P wave in leads II, III, or aVF > 2.5 mm or positive P wave in V1 > 1.5 mm had specificities of 100% and 96%, respectively, for diagnosing CMR RAE. Both criteria had a NPV of 90%, indicating low rates of false-negative results.

Association of hypertension with ECG LAE

Because hypertension may affect P wave characteristics on ECG independently of atrial size [37], we performed logistic regression to assess the independent relationships of hypertension and CMR LAE to ECG LAE. With simultaneous adjustment, only CMR LAE, and not the presence of hypertension, was significantly associated with ECG LAE (OR 2.9, 95% CI 1.2 to 7.3, p = 0.023).

Discussion

The commonly used ECG criteria for atrial enlargement have been compared to anatomic atrial size by M-mode or 2-D echocardiography [15–23, 38], which have inherent disadvantages including limited acoustic windows and spatial resolution, geometric assumptions made for estimation of atrial size, and moderate interobserver variability of measurements. The goal of this study was to characterize the accuracy of commonly used ECG atrial enlargement criteria against a gold standard of volumetric CMR measurements.

The presence of any ECG LAE criteria was 90% sensitive with a NPV of 84%, but had poor specificity of only 21% for CMR LAE. Using a combination of ECG LAE criteria is thus highly sensitive for detection of anatomic LAE, with a low false negative rate. This study indicates that commonly used ECG LAE criteria are more sensitive for anatomic LAE than the 6–69% sensitivity previously reported using echocardiographic standards [16, 18, 22, 23, 38]. The criteria of P mitrale, P wave axis < 30°, and terminal P wave in V1 > 0.04s·mm were each highly specific although not sensitive for CMR LAE. In our CMR study, we found higher specificities of P mitrale and terminal P wave in V1 > 0.04s·mm for anatomic LAE than those obtained by similar atrial bi-plane volume analysis using 2-D echocardiography [38]. In addition, the high specificity of the criteria of P wave axis < 30° to detect LAE has not been previously described to our knowledge. Compared with prior M-mode echocardiographic studies [16, 18, 23, 25], we found higher sensitivity but lower specificity for P > 0.11s, and similar excellent specificity for P mitrale and NPTF-V1 > 0.04s·mm to detect CMR LAE. The overall increased sensitivity of ECG LAE compared to ECG RAE may be explained by a larger number of criteria used, as well as high prevalence of the very sensitive criteria P > 0.11s.

Our results indicate that ECG criteria are insensitive but highly specific to detect CMR RAE, and are in agreement with analyses using echocardiographic volumetric RAE [39]. We found similar sensitivity but greatly improved specificity and both positive and negative predictive values of ECG for CMR RAE compared to 2-D echocardiographic standards [40]. No individual ECG criteria had both high sensitivity and specificity for predicting anatomic RAE. Though many of the commonly used individual ECG LAE and RAE criteria have high specificity for anatomic AE, their prevalence is rare even in our referral population.

Our CMR measurements are in agreement with Anderson et al [41], who reported higher CMR normative upper reference range atrial dimensions compared to echocardiographic standards. Though our mean volume indices exceed normative values by the American Society of Echocardiography [42], CMR volumetric measures have been shown to exceed that of echocardiography by 14–37% [41, 43]. CMR measurements in this study are consistent with those obtained in past CMR studies [29, 32–36], which published upper limits of normative LA volumes ranging 50–69 ml/m2. Within CMR studies, there is a range of volumes reported in healthy subjects, with smaller volumes found in studies with younger, as opposed to middle-aged, subjects [36, 44, 45].

Abnormalties in atrial conduction resulting from hypertension, elevated pulmonary capillary wedge pressure, or intrinsic conduction defects are associated with abnormalities in the P wave [37, 46, 47] and may be independent of atrial size. Thus, it is not surprising that in our study, ECG LAE criteria were sensitive but not specific. Since multiple etiologies may account for similar conduction disturbances in the P wave, the manifestation of such ECG criteria may be more accurately described as indicating atrial "abnormality" rather than "enlargement".

In logistic regression analysis, we demonstrated that CMR LAE was associated with ECG LAE independently of hypertension. However, a limitation of our study was that we were not able to adjust for other factors which may affect P wave morphology, such as the use of sodium channel blocking medications, as this information was unavailable. In addition, since this study was noninvasive, we were not able to measure atrial pressures, which may also affect the P wave [46].

Conclusion

Our results further validate the strengths and weaknesses of commonly used ECG LAE and RAE criteria against the gold standard of anatomic measurements. Compared with volumetric CMR measures, none of the commonly used ECG LAE or RAE criteria provided high accuracy for detecting anatomic LAE or RAE. High sensitivity was achieved only with lower specificity and vice versa. The presence of any ECG LAE criteria and the individual criterion of P > 0.11s were highly sensitive for CMR LAE, while the criteria P mitrale, P wave axis < 30°, and NPTF-V1 > 0.04s·mm were very specific, though poorly sensitive, for detecting CMR LAE. ECG RAE criteria were highly specific, though insensitive, for detecting anatomic RAE. The limited specificity of the most sensitive ECG criteria for anatomic atrial enlargement is consistent with the fact that P wave perturbations reflect changes in atrial conduction, which may be due to a variety of etiologies. Thus, the term atrial "abnormality" may be more appropriate than "enlargement" to describe such ECG findings.

Declarations

Authors’ Affiliations

(1)
Harvard-Thorndike Laboratory and the Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts, USA
(2)
Cardiovascular and Metabolic Division, GlaxoSmithKline Pharmaceuticals, 1250 Collegeville Road, Collegeville, Pennsylvania, USA
(3)
Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts, USA

References

  1. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB: Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002, 90 (12): 1284-9. 10.1016/S0002-9149(02)02864-3.View ArticlePubMedGoogle Scholar
  2. Alsaileek AA, Osranek M, Fatema K, McCully RB, Tsang TS, Seward JB: Predictive value of normal left atrial volume in stress echocardiography. J Am Coll Cardiol. 2006, 47 (5): 1024-8. 10.1016/j.jacc.2005.09.069.View ArticlePubMedGoogle Scholar
  3. Altunkeser BB, Ozdemir K, Gok H, Temizhan A, Tokac M, Karabag T: Can P wave parameters obtained from 12-lead surface electrocardiogram be a predictor for atrial fibrillation in patients who have structural heart disease?. Angiology. 2003, 54 (4): 475-9.View ArticlePubMedGoogle Scholar
  4. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahlof B, Devereux RB: Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002, 39 (3): 739-43. 10.1161/hy0302.105683.View ArticlePubMedGoogle Scholar
  5. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB: Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001, 76 (5): 467-75.View ArticlePubMedGoogle Scholar
  6. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB: Risks for atrial fibrillation and congestive heart failure in patients >/= 65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol. 2004, 93 (1): 54-8. 10.1016/j.amjcard.2003.09.012.View ArticlePubMedGoogle Scholar
  7. Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG, Bailey KR, Petty GW, Weibers DO, Tsang TS: Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc. 2004, 79 (8): 1008-14.View ArticlePubMedGoogle Scholar
  8. Modena MG, Muia N, Sgura FA, Molinari R, Castella A, Rossi R: Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study. Clin Cardiol. 1997, 20 (6): 553-60.View ArticlePubMedGoogle Scholar
  9. Moller JE, Hillis GS, Oh JK, Seward JB, Reeder GS, Wright RS, Park SW, Bailey KR, Pellikka PA: Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation. 2003, 107 (17): 2207-12. 10.1161/01.CIR.0000066318.21784.43.View ArticlePubMedGoogle Scholar
  10. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB: Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?. J Am Coll Cardiol. 2006, 47 (5): 1018-23. 10.1016/j.jacc.2005.08.077.View ArticlePubMedGoogle Scholar
  11. Verma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, Ghali JK, Velazquez EJ, McMurray JJ, Pfeffer MA, Solomon SD: The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study. J Am Coll Cardiol. 2007, 50 (13): 1238-45. 10.1016/j.jacc.2007.06.018.View ArticlePubMedGoogle Scholar
  12. Tsang TS, Barnes ME, Gersh BJ, Takemoto Y, Rosales AG, Bailey KR, Seward JB: Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol. 2003, 42 (7): 1199-205. 10.1016/S0735-1097(03)00943-4.View ArticlePubMedGoogle Scholar
  13. Fonseca C, Mota T, Morais H, Matias F, Costa C, Oliveira AG, Ceia F: The value of the electrocardiogram and chest X-ray for confirming or refuting a suspected diagnosis of heart failure in the community. Eur J Heart Fail. 2004, 6 (6): 807-12. 10.1016/j.ejheart.2004.09.004. 821–2View ArticlePubMedGoogle Scholar
  14. Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Schwartz T, Koch G, Clayton LM, Jobsis MM, Crow JW, Long W: Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002, 39 (7): 1214-9. 10.1016/S0735-1097(02)01744-8.View ArticlePubMedGoogle Scholar
  15. Chirife R, Feitosa GS, Frankl WS: Electrocardiographic detection of left atrial enlargement. Correlation of P wave with left atrial dimension by echocardiography. Br Heart J. 1975, 37 (12): 1281-5. 10.1136/hrt.37.12.1281.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Hazen MS, Marwick TH: Underwood DA. Diagnostic accuracy of the resting electrocardiogram in detection and estimation of left atrial enlargement: an echocardiographic correlation in 551 patients. Am Heart J. 1991, 122 (3 Pt 1): 823-8. 10.1016/0002-8703(91)90531-L.View ArticlePubMedGoogle Scholar
  17. Hopkins CB, Barrett O: Electrocardiographic diagnosis of left atrial enlargement. Role of the P terminal force in lead V1. J Electrocardiol. 1989, 22 (4): 359-63. 10.1016/0022-0736(89)90012-5.View ArticlePubMedGoogle Scholar
  18. Munuswamy K, Alpert MA, Martin RH, Whiting RB, Mechlin NJ: Sensitivity and specificity of commonly used electrocardiographic criteria for left atrial enlargement determined by M-mode echocardiography. Am J Cardiol. 1984, 53 (6): 829-32. 10.1016/0002-9149(84)90413-2.View ArticlePubMedGoogle Scholar
  19. Perosio AM, Suarez LD, Torino A, Llera JJ, Ballester A, Roisinblit JM: Reassessment of electrovectorcardiographic signs of left atrial enlargement. Clin Cardiol. 1982, 5 (12): 640-6.View ArticlePubMedGoogle Scholar
  20. Reeves WC: ECG criteria for right atrial enlargement. Arch Intern Med. 1983, 143 (11): 2155-6. 10.1001/archinte.143.11.2155.View ArticlePubMedGoogle Scholar
  21. Rubler S, Shah NN, Moallem A: Comparison of left atrial size and pulmonary capillary pressure with P wave of electrocardiogram. Am Heart J. 1976, 92 (1): 73-8. 10.1016/S0002-8703(76)80405-X.View ArticlePubMedGoogle Scholar
  22. van Dam I, Roelandt J, Robles de Medina EO: Left atrial enlargement: an electrocardiographic misnomer? An electrocardiographic-echocardiographic study. Eur Heart J. 1986, 7 (2): 115-7.PubMedGoogle Scholar
  23. Waggoner AD, Adyanthaya AV, Quinones MA, Alexander JK: Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation. 1976, 54 (4): 553-7.View ArticlePubMedGoogle Scholar
  24. Lester SJ, Ryan EW, Schiller NB, Foster E: Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999, 84 (7): 829-32. 10.1016/S0002-9149(99)00446-4.View ArticlePubMedGoogle Scholar
  25. Ikram H, Drysdale P, Bones PJ, Chan W: The non-invasive recognition of left atrial enlargement: comparison of electro- and echocardiographic measurements. Postgrad Med J. 1977, 53 (621): 356-9.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Chou TC: Atrial abnormalities. In Electrocardiography in Clinical Practice. Electrocardiography in Clinical Practice. Edited by: Chou TC. 1991, Philadelphia: W.B. Saunders, 29-35. 3Google Scholar
  27. Friedman H: Atrial abnormalities. Diagnostic Electrocardiography and Vectorcardiography. 1985, New York: McGraw-Hill, 3Google Scholar
  28. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18 (12): 1440-63. 10.1016/j.echo.2005.10.005.View ArticlePubMedGoogle Scholar
  29. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S: Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005, 7 (5): 775-82. 10.1080/10976640500295516.View ArticlePubMedGoogle Scholar
  30. Sievers B, Kirchberg S, Addo M, Bakan A, Brandts B, Trappe HJ: Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson. 2004, 6 (4): 855-63. 10.1081/JCMR-200036170.View ArticlePubMedGoogle Scholar
  31. Jarvinen VM, Kupari MM, Hekali PE, Poutanen VP: Right atrial MR imaging studies of cadaveric atrial casts and comparison with right and left atrial volumes and function in healthy subjects. Radiology. 1994, 191 (1): 137-42.View ArticlePubMedGoogle Scholar
  32. Jarvinen VM, Kupari MM, Poutanen VP, Hekali PE: Right and left atrial phasic volumetric function in mildly symptomatic dilated and hypertrophic cardiomyopathy: cine MR imaging assessment. Radiology. 1996, 198 (2): 487-95.View ArticlePubMedGoogle Scholar
  33. Jarvinen VM, Kupari MM, Poutanen VP, Hekali PE: A simplified method for the determination of left atrial size and function using cine magnetic resonance imaging. Magn Reson Imaging. 1996, 14 (3): 215-26. 10.1016/0730-725X(95)02098-E.View ArticlePubMedGoogle Scholar
  34. Therkelsen SK, Groenning BA, Svendsen JH, Jensen GB: Atrial and ventricular volume and function in persistent and permanent atrial fibrillation, a magnetic resonance imaging study. J Cardiovasc Magn Reson. 2005, 7 (2): 465-73. 10.1081/JCMR-200053618.View ArticlePubMedGoogle Scholar
  35. Therkelsen SK, Groenning BA, Svendsen JH, Jensen GB: Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol. 2006, 97 (8): 1213-9. 10.1016/j.amjcard.2005.11.040.View ArticlePubMedGoogle Scholar
  36. Tseng WY, Liao TY, Wang JL: Normal systolic and diastolic functions of the left ventricle and left atrium by cine magnetic resonance imaging. J Cardiovasc Magn Reson. 2002, 4 (4): 443-57. 10.1081/JCMR-120016383.View ArticlePubMedGoogle Scholar
  37. Di Bianco R, Gottdiener JS, Fletcher RD, Pipberger HV: Left atrial overload: a hemodynamic, echocardiographic, electrocardiographic and vectorcardiographic study. Am Heart J. 1979, 98 (4): 478-89. 10.1016/0002-8703(79)90255-2.View ArticlePubMedGoogle Scholar
  38. Lee KS, Appleton CP, Lester SJ, Adam TJ, Hurst RT, Moreno CA, Altemose GT: Relation of electrocardiographic criteria for left atrial enlargement to two-dimensional echocardiographic left atrial volume measurements. Am J Cardiol. 2007, 99 (1): 113-8. 10.1016/j.amjcard.2006.07.073.View ArticlePubMedGoogle Scholar
  39. Kaplan JD, Evans GT, Foster E, Lim D, Schiller NB: Evaluation of electrocardiographic criteria for right atrial enlargement by quantitative two-dimensional echocardiography. J Am Coll Cardiol. 1994, 23 (3): 747-52.View ArticlePubMedGoogle Scholar
  40. Reeves WC, Hallahan W, Schwiter EJ, Ciotola TJ: Buonocore E, Davidson W. Two-dimensional echocardiographic assessment of electrocardiographic criteria for right atrial enlargement. Circulation. 1981, 64 (2): 387-91.View ArticlePubMedGoogle Scholar
  41. Anderson JL, Horne BD, Pennell DJ: Atrial dimensions in health and left ventricular disease using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2005, 7 (4): 671-5.PubMedGoogle Scholar
  42. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W: Recommendations for chamber quantification. Eur J Echocardiogr. 2006, 7 (2): 79-108. 10.1016/j.euje.2005.12.014.View ArticlePubMedGoogle Scholar
  43. Rodevan O, Bjornerheim R, Ljosland M, Maehle J, Smith HJ, Ihlen H: Left atrial volumes assessed by three- and two-dimensional echocardiography compared to MRI estimates. Int J Card Imaging. 1999, 15 (5): 397-410. 10.1023/A:1006276513186.View ArticlePubMedGoogle Scholar
  44. Poutanen T, Jokinen E, Sairanen H, Tikanoja T: Left atrial and left ventricular function in healthy children and young adults assessed by three dimensional echocardiography. Heart. 2003, 89 (5): 544-9. 10.1136/heart.89.5.544.PubMed CentralView ArticlePubMedGoogle Scholar
  45. Raman SV, Ng VY, Neff MA, Sayar S, Sparks EA, Nelson SD, Ferketich AK, Wooley CF: Volumetric cine CMR to quantify atrial structure and function in patients with atrial dysrhythmias. J Cardiovasc Magn Reson. 2005, 7 (3): 539-43. 10.1081/JCMR-200062772.View ArticlePubMedGoogle Scholar
  46. Josephson ME, Kastor JA, Morganroth J: Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlates. Am J Cardiol. 1977, 39 (7): 967-71.View ArticlePubMedGoogle Scholar
  47. Saunders JL, Calatayud JB, Schulz KJ, Maranhao V, Gooch AS, Goldberg H: Evaluation of ECG criteria for P-wave abnormalities. Am Heart J. 1967, 74 (6): 757-65. 10.1016/0002-8703(67)90095-6.View ArticlePubMedGoogle Scholar

Copyright

© Tsao et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us